Clinical Trials Directory

Trials / Completed

CompletedNCT05113199

Virtual Dignity Therapy for Palliative Care Patients With Advanced Cancer

Feasibility and Acceptability of Virtual Dignity Therapy for Palliative Care Patients With Advanced Cancer

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
21 (actual)
Sponsor
Mayo Clinic · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to determine if it is feasible and acceptable to recruit for and deliver the Virtual Dignity Therapy intervention to palliative care patients with advanced cancer.

Detailed description

This study is an investigator-initiated, single site Mayo Clinic Rochester prospective minimal risk pilot study to determine feasibility and acceptability of Virtual Dignity Therapy. The Dignity Therapy intervention is a brief, individualized psychotherapy that aims to relieve psycho-emotional and existential distress and improve the experiences of patients whose lives are impacted by serious illness. This therapy offers patients an opportunity to reflect on their life with a trained facilitator and share their thoughts and memories with family and other people in their life. This therapy consists of a total of 3 sessions, with each session 2-4 weeks apart, in which the investigator provides questions focused on life review. The sessions are recorded and transcribed. The interventionist will work with patients to edit the document and provide a final generativity document for patient to keep and give to loved ones.

Conditions

Interventions

TypeNameDescription
BEHAVIORALVirtual Dignity TherapyVirtual Dignity Therapy will be facilitated by a registered nurse or medical doctor trained in Dignity Therapy.

Timeline

Start date
2021-11-18
Primary completion
2025-02-17
Completion
2025-02-17
First posted
2021-11-09
Last updated
2025-03-03

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05113199. Inclusion in this directory is not an endorsement.